Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738517015 | Benzocaine and salicylamide only product in cutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3738518013 | Product containing only benzocaine and salicylamide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Benzocaine and salicylamide only product in cutaneous dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Benzocaine and salicylamide only product in cutaneous dose form | Is a | Benzocaine- and salicylamide-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Benzocaine and salicylamide only product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Benzocaine and salicylamide only product in cutaneous dose form | Has active ingredient | Salicylamide | true | Inferred relationship | Some | 1 | |
| Benzocaine and salicylamide only product in cutaneous dose form | Has active ingredient | Benzocaine | true | Inferred relationship | Some | 2 | |
| Benzocaine and salicylamide only product in cutaneous dose form | Is a | Benzocaine and salicylamide only product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel | Is a | True | Benzocaine and salicylamide only product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR